Prognostic influences of B-cell lymphoma 2-positive expression on late recurrence in breast cancer.
Hee Ju KimYong Hwa EomSeung Hye ChoiPublished in: Annals of surgical treatment and research (2023)
Our result showed that prognosis was better in BCL2-positive patients compared to BCL2-negative patients at late recurrence. We suggested that BCL2 expression could be used as a marker to help determine additional adjuvant therapy or extended hormone therapy in hormone-dependent breast cancer.